|
|
Volumn 32 Suppl 2, Issue , 2009, Pages
|
|
American Diabetes Association indications for statins in diabetes: is there evidence?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
ADULT;
BLOOD;
DIABETES MELLITUS;
DRUG EFFECT;
EVIDENCE BASED MEDICINE;
HUMAN;
LIFESTYLE;
MEDICAL SOCIETY;
METHODOLOGY;
PRIMARY PREVENTION;
REVIEW;
RISK ASSESSMENT;
SECONDARY PREVENTION;
ADULT;
ANTILIPEMIC AGENTS;
CHOLESTEROL, LDL;
DIABETES MELLITUS;
EVIDENCE-BASED MEDICINE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIFE STYLE;
PRIMARY PREVENTION;
RISK ASSESSMENT;
SECONDARY PREVENTION;
SIMVASTATIN;
SOCIETIES, MEDICAL;
MLCS;
MLOWN;
|
|
EID: 75549086896
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-s345 Document Type: Review |
|
Times cited : (53)
|
|
References (37)
|
